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Abstract
Background: The cellular immune response for Mycobacterium tuberculosis (M. tuberculosis) infection remained
incompletely understood. To uncover membrane proteins involved in this infection mechanism, an integrated
approach consisting of an organic solvent-assisted membrane protein digestion, stable-isotope dimethyl labeling
and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis was used to comparatively profile the
membrane protein expression of human dendritic cells upon heat-killed M. tuberculosis (HKTB) treatment.
Results: Organic solvent-assisted trypsin digestion coupled with stable-isotope labeling and LC-MS/MS analysis was
applied to quantitatively analyze the membrane protein expression of THP-1 derived dendritic cells. We evaluated
proteins that were upregulated in response to HKTB treatment, and applied STRING website database to analyze
the correlations between these proteins. Of the investigated proteins, aminopeptidase N (CD13) was found to be
largely expressed after HKTB treatment.
By using confocal microscopy and flow cytometry, we found that membranous CD13 expression was upregulated
and was capable of binding to live mycobacteria. Treatment dendritic cell with anti-CD13 antibody during
M. tuberculosis infection enhanced the ability of T cell activation.
Conclusions: Via proteomics data and STRING analysis, we demonstrated that the highly-expressed CD13 is also
associated with proteins involved in the antigen presenting process, especially with CD1 proteins. Increasing
expression of CD13 on dendritic cells while M. tuberculosis infection and enhancement of T cell activation after
CD13 treated with anti-CD13 antibody indicates CD13 positively involved in the pathogenesis of M. tuberculosis.
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Background
Despite many effective treatments are available, M.
tuberculosis remains one of the most successful patho-
gens on the planet, estimated to have infected nearly
one-third of the human population and cause approxi-
mately 1.7 million deaths each year [1]. M. tuberculosis
is typically transmitted via the inhalation of aerosol
droplets containing the pathogen. Once inhaled, these
small droplets can spread into distal lung alveoli, where
they are phagocytosed by alveolar macrophages [2].
Once inside the macrophage, M. tuberculosis prevents
its phagosome from fusing with digestive lysosomes [3],
allowing the pathogen to lay dormant within its host.
While macrophages are the primary targets of the
mycobacteria, M. tuberculosis’s ability to exist as latent
infection suggests that it is also able to suppress other
immune responses. Following the initial macrophage re-
sponse is an acute inflammatory response, causing a
rapid recruitment of dendritic cells (DCs) into the air-
way epithelium [4]. Normally, DCs capture the bacteria,
process them, and present their antigens on their cell
surfaces to various cells of the immune system. However,
it is suggested that specific functions of DCs may be
modulated by the mycobacteria. More specifically,
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M. tuberculosis has been show to infect DCs and disrupt
their capacity to activate and induce primary immune
responses in resting naïve T lymphocytes [5–7].
While M. tuberculosis infection of macrophages has
been studied extensively, little is known about the mech-
anisms that the mycobacterium uses to mediate cell
entry into human DCs. It is plausible that many host
factors with important functions and potential thera-
peutic value have not yet been evaluated. Thus, a global
analysis of membrane protein expression in human DCs
treated with M. tuberculosis could potentially provide
further information about the pathogenic mechanisms of
tuberculosis. Unfortunately, it is challenging to run a
large-scale identification and quantitation of membrane
proteins, specifically due to their hydrophobic natures
that retard both solubilization in aqueous buffers and
downstream enzymatic digestion in a regular bottom-
up protein identification pipeline [8, 9]. Recently,
possible solutions including formic acid-CNBr/trypsin
[10]、high pH/proteinase K [11]、detergent-assisted
approach [12]、organic solvent-assisted digestion [13]
and tube-gel assisted approach [14, 15] have been used in
large-scale membrane proteome studies. Among these
methods, the 60 % methanol-assisted trypsin digestion is
relatively simple, and the use of a methanol-based buffer
circumvents the need for reagents that interfere with
chromatographic separation and ionization of the peptides
(e.g., detergents, chaotropes, nonvolatile salts). For quanti-
tative aspects, isotope-coded affinity tag [16], isotope
coded protein labeling [17], 18O labeling [18], stable iso-
tope dimethyl labeling [19], stable isotope labeling by
amino acids in cell culture [20] and isobaric tags for rela-
tive and absolute quantitation [15, 21] have been intro-
duced for use in comparative membrane proteomics as
well as in identification of membrane proteins. Due to its
simplicity, effectiveness, and—most importantly—organic
solvent compatibility, dimethyl labeling can be efficiently
used with 60 % methanol-assisted trypsin digestion of
membrane proteins [18]. Therefore, in this study, 60 %
methanol-assisted trypsin digestion coupled with this
stable-isotope labeling and LC-MS/MS analysis were ap-
plied to quantitatively analyze membrane protein expression
in THP-1–derived DCs, professional antigen-presenting
cells that link the innate and adaptive immunities.
After evaluating proteins that were upregulated in re-
sponse to heat-killed M. tuberculosis treatment, the
STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) website database was utilized to analyze
associations between these proteins. Of the investigated
proteins, aminopeptidase N (CD13) was found to be
largely expressed after HKTB treatment. CD13 is a peptid-
ase that affects T cell response by mediating the trimming
of major histocompatibility complex (MHC) class II pep-
tides [22], and is also an adhesion molecule involved in
leukocyte transendothelial migration into inflammatory
sites [23]. In addition, CD13 is involved in phagocytic pro-
cesses in macrophages and DCs [24]. Recently we have re-
ported that M. tuberculosis utilizes CD13 as a mediator of
cell entry in human monocytes and macrophages [25].
However, little is known about CD13’s role in mycobacter-
ial interactions with dendritic cells. The results of our
study suggest that besides its known functions, CD13 is
used by M. tuberculosis as an important mediator of cell
entry in human dendritic cells to impair the antigen-
presenting process and prevent T cell activation.
Results
Proteomic profiling of membrane proteins from
THP-1-derived DCs treated with or without HKTB
To uncover membrane proteins involved in M. tubercu-
losis infection, an integrated approach consisting of 60 %
methanol-assisted membrane protein digestion, stable-
isotope dimethyl labeling, LC-MS/MS analysis and data-
base searching was used to comparatively profile the
membrane protein expression of THP-1-derived DCs
treated with or without HKTB. The membrane proteins
of THP-1-derived DCs were extracted by the use of
ReadyPrep Membrane II Protein Extraction kit accord-
ing to the manufacturer’s instructions. A total of 184
proteins derived from the membrane fraction of THP-1-
derived DCs treated with or without HKTB were identi-
fied through this integrated approach (MascotProtein
score and numbers of matched peptide were included in
Additional file 1: Table S1). About 62.5 % of proteins
were identified as membrane proteins from plasma,
endoplasmic reticulum/Golgi, mitochondria, microsome,
peroxisome, endosome and lysosome membranes ac-
cording to their subcellular location shown in UniProt
database. Among 49 membrane proteins (around 27 %
of total proteins), which were identified as surface mem-
brane proteins, 34 proteins were detected with expres-
sion ratios more than 2 and one protein with expression
ratios less than 1 when their relative abundance was
compared in treated and non-treated samples (Table 1).
The ratio distributions of most identified proteins were
~2. These ratios did not converge well into a single
value, which may be due to the variance of membrane
protein extraction between treated and non-treated sam-
ples. Without a reliable internal standard in these identi-
fied proteins, a statistic approach was used to discriminate
proteins with up or down regulations. We used the aver-
age ratio of the membrane proteins (2.48) and standard
derivation of these ratios (1.41) to roughly distinguish pro-
teins with significant expression.
To further investigate the role of those up-regulated
proteins in mycobacterial infection, STRING database
with known and predicted protein-protein interactions
was used for functional clustering. The correlations of
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these over-expressed membrane proteins were shown in
Fig. 1. Several functional clusters including proteins
involved in extracellular peptide breakdown, antigen
presentation, phagosome maturation and markers of
dendritic cells were derived from the STRING database.
Among these proteins, GGT5 and CD13 are the top two
proteins with highest expression ratios (8.7 and 5.2, re-
spectively). To determine which protein would be much
relevant in response to clinical tuberculosis, we analyze the
expression of GGT5 and CD13 in circulating monocytes
from patients with active tuberculosis. The trend of CD13
expression in circulating monocytes from patients with ac-
tive tuberculosis is also increased as seen in the proteomic
analysis. By contrast, the expression of GGT5 in circulat-
ing monocytes from patients with active tuberculosis was
decreased, which was not compatible to the data seen in
proteomic analysis (unpublished observations). Due to its
high expression ratio in both in-vitro and clinical samples
and potential immune modulatory functions, CD13 was
chosen for further study.
Table 1 Identified major proteins increased/decreased in response to HKTB stimulation
No. Name Protein description Ratio
1 GGT5 Gamma-glutamyltransferase 5 precursor 8.7
2 ANPEP Aminopeptidase N, CD13 5.2
3 B*15 HLA class I histocompatibility antigen, B-15 alpha chain precursor 4.6
4 SEL1L Sel-1 homolog precursor 3.7
5 SLC3A2 4F2 cell-surface antigen heavy chain 3.5
6 VAPA Vesicle-associated membrane protein-associated protein A 3.4
7 CD74 HLA class II histocompatibility antigen gamma chain 3.4
8 C20orf3 Adipocyte plasma membrane-associated protein 3.4
9 ITGAL Integrin alpha-L precursor 3.3
10 SLC2A5 Solute carrier family 2, facilitated glucose transporter member 5 3.3
11 GGT1 Gamma-glutamyltranspeptidase 1 precursor 3.2
12 ATP1B1 Sodium/potassium-transporting ATPase subunit beta-1 3.1
13 ITGAX Integrin alpha-X precursor 3.0
14 TM9SF4 Transmembrane 9 superfamily protein member 4 3.0
15 CPM Carboxypeptidase M precursor 2.9
16 CD1A T-cell surface glycoprotein CD1a precursor (CD1a antigen) 2.9
17 PTPRC Leukocyte common antigen precursor 2.9
18 SLC1A5 Neutral amino acid transporter B(0) (ATB(0)) 2.7
19 RAB10 Ras-related protein Rab-10 2.6
20 RAP2A Ras-related protein Rap-2b precursor 2.6
21 TCIRG1 Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3 2.6
22 KIAA0090 Protein KIAA0090 precursor - 2.5
23 TBXAS1 Thromboxane-A synthase (Cytochrome P450 5A1) 2.5
24 ATP1A1 Sodium/potassium-transporting ATPase alpha-1 chain precursor 2.5
25 CD1C T-cell surface glycoprotein CD1c precursor (CD1c antigen) 2.5
26 HLA-DR15 HLA class II histocompatibility antigen, DRB1-1 beta chain precursor 2.4
27 TECR Synaptic glycoprotein SC2 2.4
28 CCDC47 Coiled-coil domain-containing protein 47 precursor 2.3
29 RAB5A Ras-related protein Rab-5A 2.3
30 ITGB2 Integrin beta-2 precursor (Cell surface adhesion glycoproteins LFA-1/CR3/subunit beta) 2.2
31 ATP6V1B1 Vacuolar ATP synthase subunit B, kidney isoform 2.2
32 EFR3A Protein KIAA0143 (Fragment) 2.1
33 ESYT1 Protein FAM62A (Membrane-bound C2 domain-containing protein) 2.0
34 SCAMP2 Secretory carrier-associated membrane protein 2 2.0
35 CAP1 Adenylyl cyclase-associated protein 1 0.82
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The expression of CD13 was confirmed by Western
blotting as shown in Fig. 2a. For THP-1-derived DCs,
HKTB promoted the expression of CD 13 as compared
to control (HKTB/ control ratio =3.28± 0.44 ), even
higher than those by inflammatory stimuli, such as lipo-
polysaccharide (LPS) and tumor necrosis factor alpha
(TNF-α). Furthermore, THP-1-derived DCs and human
monocyte-derived DCs were treated with HKTB for
48 h, and surface CD13 expression was evaluated by
flow cytometry (Fig. 2b). For THP-1-derived DCs, HKTB
significantly increased the expression of CD13 (ratio =
1.56 ± 0.05, P = 0.0113). For human DCs, driven from
freshly isolated PBMC, HKTB also significantly increased
the expression of CD13 (ratio = 1.52 ± 0.07, P = 0.0214).
CD13 mediated the binding and entry of live
M. tuberculosis onto human DCs
To assess whether M. tuberculosis interacts with CD13,
the binding and entry of live M. tuberculosis through
surface CD13 of human DCs were examined by confocal
microscopy at different time points. Figure 3 shows the
results that were obtained in a representative experiment.
As M. tuberculosis infected human DCs (multiplicity of in-
fection (MOI) = 10) at an indicated time, the samples were
fixed by formalin addition to stop the interaction between
cells and bacteria. The slides were stained and mounted for
subsequent analysis of the mycobacteria-binding process
through surface CD13 by confocal microscopy. In the be-
ginning, most mycobacteria were found in the extracellular
region and few of them were partially attached to cell sur-
face (Fig. 3a, left panel). As the incubation period in-
creased, M. tuberculosis were colocalized with the surface
CD13 and internalized into the DC cytoplasm (Fig. 3a,
middle panel). After that, most mycobacteria were found
inside the DCs (Fig. 3a, right panel). The picture inside
each panel shows a drawing of partial enlargement ob-
served in confocal microscopic analysis. The lines traced
on the interface of DCs/M. tuberculosis depicts the lineal
regions of interest that were analyzed using the Lieca con-
focal software. As shown in each panel of Fig. 3a, analysis
of the profiles of green/red channel of these cells con-
firmed that mycobacteria attached to the surface CD13 of
human DCs and were internalized through the bind-
ing of the CD13 protein. Interestingly, we observed some
Fig. 1 The correlations of these over-expressed membrane proteins. The 34 membrane proteins were analyzed using the open source database
and network program STRING, resulting in networks summarized in this figure. Proteins were grouped according to their reported functions,
included four clusters (antigen presentation process, peptidase and transferase, vesicle trafficking and phagosome acidification/maturation).
Analysis of these networks revealed ANPEP (aminopeptidase, CD13) associated with proteins involved in antigen presentation
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mycobacteria still co-localized with CD13 in the cell cyto-
plasm after 60 min incubation whereas some mycobacteria
escaped from the endocytic vesicles and resided freely
(Fig. 3b). In summary, we infer that the membranous CD13
on DCs is capable of binding to live mycobacteria.
CD13 is involved in the inhibition of CD1 expression and
T cell response by HKTB
It has been demonstrated that CD13 is involved in cell-
surface antigen processing [22], and the CD13 on DCs
are able to selectively and efficiently degrade exogen-
ously provided peptide antigens [26] and further influ-
ence the capability of triggering T cells. We also wanted
to clarify whether CD13 was involved in the lipid anti-
gen presenting process. For this reason, we further stud-
ied the influence of highly expressed CD13 molecules in
HKTB-stimulated human DCs on CD1 expression and T
cell response.
As we used HKTB to stimulate the completely differ-
entiated DC, expressions of CD1b and CD1c decreased.
Fig. 2 CD13 expression is enhanced on THP-1 derived DCs and human DCs as stimulated with HKTB. a Western blotting showing the changes in
CD13 level in THP-1 derived DCs treated with LPS and TNF-alpha and HKTB with respect to medium-treated control cells. Protein expressions
were quantified by densitometric analysis and CD13 were normalized to the beta-actin of each sample. These experiments were each conducted
three times and the results are shown. b Flow cytometry analysis of THP-1 derived DCs, and human DCs stained for CD13 antibody and appropriate
isotype controls (open histograms). The filled black and gray histograms represent CD13 expression of cells with or without HKTB treatment,
respectively. The fluorescence intensity of CD13 was shown as means ± SEM (n = 3)
Fig. 3 CD13 mediated the binding and entry of live M. tuberculosis onto human DCs. a The course of M. tuberculosis binding to the CD13 and
entering into dendritic cells was shown by a series of representative cells. Confocal microscopy showing CD13 on dendritic cells surface stained
with anti-CD13 antibody (red); M. tuberculosis stained with Auramin-Rhodamin T (green); cell nucleus stained with DAPI (blue); colocalization of
M. tuberculosis with membrane-bound CD13 on dendritic cells (yellow). The profile quantification tool provided by the Leica confocal software
was used to obtain graphs with the profiles of intensities of CD13 and M. tuberculosis along lineal regions of interest (ROI). b At 60 min of incubation,
most M. tuberculosis was found inside the DCs. Scale bar, 25 μm
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Furthermore, with statistical significance, increasing sti-
mulation with HKTB led to decreasing expressions of
CD1 (Fig. 4). We found that HKTB infection of human
DCs strongly inhibited CD1b, and, to a lesser extent, CD1c,
compared to non-infected DCs with statistical differences
(P = 0.0013 and P = 0.0342, respectively) (Fig. 4a-c). The ex-
pression of CD1 represents its non-peptide antigen pres-
entation capability. CD1b and CD1c each present different
glycolipids. LAM in the cell wall of M. tuberculosis is ma-
jorly presented by CD1b [27]. The expression of CD1b
and CD1c are affected significantly by stimulation with
LAM (P = 0.0067 and P = 0.0271, respectively) (Fig. 4f-g).
We found that the affects of HKTB on CD1c could be re-
versed by an anti-CD13 antibody (WM15), which also
subsequently enhanced the ability of DCs to trigger T cell
proliferation (Fig. 4d). We also observed the same trends
with LAM treatments (Fig. 4h).
Discussion
Proteins upregulated in human DCs after HKTB treat-
ment engaged in a diverse range of cellular processes
(Fig. 1 and Table 1), suggesting a complex interaction
between the bacterium and its host. A proteomic ana-
lysis of membrane fraction proteins of THP-1–derived
DCs revealed that proteins involved in antigen presenta-
tion (HLA class I/II histocompatibility antigens, CD1a,
CD1c and CD13) were increased to confront M. tuber-
culosis infection. A cell surface binding protein, CD13
was found to be upregulated 5.2-fold upon HKTB treat-
ment. CD13 is a large cell surface peptidase expressed
on the membrane of myeloid dendritic cells [28, 29]. By
using Western blot and flow cytometry, we demon-
strated that CD13 expression on human DCs was upreg-
ulated under inflammatory conditions, especially those
induced by HKTB (Fig. 2). However, the physiological
relevance of this high expression is not fully understood
yet. We have previously reported that CD13 serves as a
receptor on monocyte/macrophages that binds to M.
tuberculosis [25], as well as a possible receptor that me-
diates of lipid uptake (unpublished observations, [30]).
Via proteomics data and STRING analysis, we demon-
strated that the highly-expressed CD13 is also associated
with proteins involved in the antigen presenting process,
especially with CD1 proteins.
CD1 presents glycolipids such as LAM [31], the most
immunogenic glycolipid antigen and a key virulence fac-
tor on mycobacterial envelopes, to a distinct group of T
cells [32]. However, M. tuberculosis has been shown to
suppress ~60-90 % of CD1a, CD1b, and CD1c expressions
on differentiating monocytes [33]. The mycobacterium
has also been shown to induce human monocytes to dif-
ferentiate into CD1-negative DCs, which cannot present
lipid antigens to specific T cells [34]. Taken together, these
studies suggest that mycobacterial impairment of cellular
immune function is strongly associated with CD1 expres-
sion [35]. In our study, HKTB and LAM treatments did
indeed inhibit the expressions of CD1b and CD1c—but
not CD1a—on immature DCs and also decreased T cell
proliferation (Fig. 4).
Interestingly, targeting CD13 helped reduce the effects
of HKTB and LAM on DCs. Using neutralized anti-
bodies to block the binding receptor CD13 partially re-
versed the effects of HKTB and LAM treatments on
CD1c expression. Because CD1c-positive DCs are an es-
sential group of DCs responsible for naïve T cell prolifer-
ation [36], these results suggest that HKTB impairs the
ability of DCs to initiate T cell responses. Further testing
confirmed that anti-CD13 antibodies also reversed the
inhibitive effects of HKTB treatment on T cell prolifera-
tion. This was a simpler approach to clarify the interac-
tions between CD13 and CD1, but our results were
compatible with STRING database analysis.
Besides revealing information about antigen-presentation,
proteomic analysis also revealed that proteins involved in
phagosome maturation (Ras-related proteins like Rab5
and Rab 10), phagosome acidification (vacuolar proton
ATPases like TCIRG1 and ATP6V1B1) and vesicle traf-
ficking (vesicle-associated/secretory carrier-associated mem-
brane proteins like VAPA and SCAMP2) were upregulated
in HKTB-treated DCs. Rab5 and Rab 10, which are both
localized to early phagosomes and are required for phago-
some maturation, were upregulated by 2.3 fold and 2.6
fold, respectively. Rab10 expression is part of a host cell
response during early stages of mycobacterial infection
that rescues Mycobacterium-containing phagosomes mat-
uration [37, 38]. Meanwhile, vacuolar proton ATPase
plays a crucial role in the acidification of phagosomes and
is an important initial determinant of mycobacterial
Ag85B processing by macrophages [39]. The upregulation
of Rab10 and vacuolar proton ATPase could reflect a host
anti-bactericidal response to HKTB treatment. We also
found that vesicle trafficking-associated proteins VAPA
and SCAMP2 were upregulated 3.4 and 2.0-fold, respect-
ively. Unfortunately, the roles of VAPA and SCAMP2 in
intracellular transport of membranes are still not clear.
Our observation that VAPA and SCAMP2 were upregu-
lated in response to HKTB is a new finding.
Although our STRING analysis didn’t reveal the direct
association between CD13 and phagosome acidification-
related proteins, CD13 has been reported to not only be
a receptor on mycobacteria, but also a mediator that
participates in phagosome acidification during M. tuber-
culosis infection [25]. As a result, further analysis is
needed to clarify CD13’s interactions with phagosome
acidication-related proteins.
Utlimately, we infer that M. tuberculosis targets CD13
on dendritic cells to the antigen-presenting process and
prevent T cell activation. However, anti-CD13 antibodies
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Fig. 4 (See legend on next page.)
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were shown to reverse the inhibitive effects of HKTB
treatment on T cell proliferation. It has been reported
that mycobacteria selectively target surface receptors like
dendritic cell-specific intercellular adhesion molecule-3
grabbing nonintegrin (DC-SIGN) [40] to immunosup-
press DC function, which prolongs the mycobacteria’s
survival. Our results suggest that clinical therapies tar-
geting the CD13 receptor may help reduce M. tubercu-
losis’ ability to bind to antigen presenting cells, thereby
preventing the inhibition of T cell activation. However,
further investigation is still needed on how exactly M.
tuberculosis enters DCs and inhibits their cell functions
through CD13.
Conclusions
These results add to a growing understanding of the in-
teractions M. tuberculosis has with the human immune
system. While CD13 is only one of a variety of mem-
brane proteins involved in M. tuberculosis infection, evi-
dence provided by this study may lay the groundwork
for future tuberculosis target therapies.
Methods
Materials
Acetonitrile (ACN), ammonium bicarbonate, 1,4-dithio-
threitol (DTT), ethylene glycol, sodium acetate and for-
maldehyde (37 % solution in H2O) were purchased from
J.T. Baker (NJ, USA). Sodium cyanoborohydride was
purchased from Riedel-de Haën (Seelze, Germany). For-
mic acid (FA), formaldehyde-D2 (20 % solution in D2O),
iodoacetamide (IAM), ammonium hydroxide solution
(33 %), phorbol-12-myristate-13-acetate (PMA) and di-
methylsulfoxide were purchased from Sigma-Aldrich
(Germany, Steinheim). Sequencing grade modified tryp-
sin was obtained from Promeg (WI, USA). RPMI 1640
media was purchased from Life Technologies Corpor-
ation (Grand Island, NY, USA). ReadyPrep Membrane II
Protein Extraction kit was obtained from Bio-Rad (CA,
USA). The water used in this study was obtained from
Milli-Q® (Millipore) water purification system (Billerica,
MA, USA). Lipoarabinomannan (LAM) from Mycobac-
terium tuberculosis Aoyama-B was purchased from
Nacalai Tesque (Kyoto, Japan).
Ethics statement
This study was conducted according to the principles
expressed in the International Conference on Harmon-
isation (ICH)/WHO Good Clinical Practice standards.
Written informed consent was obtained for participation
in the study, which was approved by the institutional re-
view board of the Mackay Memorial Hospital.
Preparation of THP-1-derived dendritic cells for stimulation
with HKTB
The THP-1 cell line (BCRC 60430) was obtained from
the Food Industry Research and Development Institute
(Hsinchu, Taiwan). THP-1 cells were grown in RPMI
1640 media containing 10 % FCS supplemented with
100 U/ml penicillin and 2 mM L-glutamine. Cells were
maintained in a humidified atmosphere with 5 % CO2 at
37 °C. Differentiating THP-1 cells into dendritic cells
was achieved by treatment of THP-1 cells with 10 ng/ml
PMA, in the presence of 100 ng/ml GM-CSF and
100 ng/ml IL-4 (Peprotech Ltd) [41]. A 10 μg/ml stock
solution of PMA was prepared by dissolving PMA in
dimethylsulfoxide. HKTB stock solution was prepared
by adding 30 ml of RPMI 1640 media into one vial of
HKTB powder (100 mg, desiccated M. tuberculosis, pur-
chased from BD Difco, GA, USA) and sonicated 5 min
for three times. THP-1-derived DCs were then treated
with HKTB (10 μg/ml) for three days.
Trypsin digestion of membrane proteins
The membrane proteins of THP-1-derived DCs were ex-
tracted by the use of ReadyPrep Membrane II Protein
Extraction kit (Bio-Rad) according to the manufacturer’s
instructions. Briefly, 100-200 mg of wet cell pellets were
lysed with lysis buffer. After the removal of insoluble
material and unbroken cells, the membrane protein frac-
tion was isolated with ice-cold Na2CO3 followed by cen-
trifugation. Pellets from the control and experimental
samples were individually dissolved and digested accord-
ing to the following procedures. Proteins in the mem-
brane fraction pellet were resuspended in 50 mM
ammonium bicarbonate (200 μl, pH 8.3) by vortex and
sonication. The proteins were denatured at 95 °C for
5 min then cooled at ice-bath temperature. Due to the
hydrophobic nature, the membrane fraction can not be
(See figure on previous page.)
Fig. 4 CD13 is involved in the inhibition of CD1 expression and T cell response by HKTB. a CD1 expression on dendritic cells infected with or
without HKTB for 48 h was measured by flow cytometry. The fluorescence intensity of CD1a was expressed relative to isotype antibody (100 %)
and shown as means ± SEM (n = 5). The fluorescence intensity of CD1b expression (b) and CD1c expression (c) were shown as means ± SEM (n = 4).
d CFSE-labeled T cells were cultured with dendritic cells for six days and T cell proliferation was analyzed by flow cytometry. These experiments were
conducted with four times and representative result of proliferation index was shown. * P <0.05. e CD1 expression on dendritic cells infected with or
without LAM for 48 h was measured by flow cytometry. The fluorescence intensity of CD1a was expressed relative to isotype antibody (100 %) and
shown as means ± SEM (n = 5). The fluorescence intensity of CD1b expression (f) and CD1c expression (g) were shown as means ± SEM (n = 4). h The
results of T cell proliferation were representative of four different experiments
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dissolved and digested well by regular digestion protocol.
Organic-assisted solubilization and proteolysis were chosen
in this study to dissolve and digest membrane proteins.
Methanol was added into the protein solution to make a
final concentration of 60 % (v/v), facilitating the solu-
bilization of most membrane proteins. Trypsin was then
immediately put into this solution in a 1/50 (w/w) trypsin-
to-protein ratio followed by incubation for 14 h at 37 °C.
The resulting peptide mixtures were lyophilized and
stored at -20 °C for further stable-isotope labeling.
Stable-isotope dimethyl-labeling of tryptic peptides
The tryptic peptides derived from the control samples
which had been dissolved in sodium acetate buffer
(100 mM, pH 5-6) were mixed with formaldehyde (4 %
in water, 5 μl), vortexed, and then immediately com-
bined with freshly prepared sodium cyanoborohydride
(1 M, 5 μl). The mixture was vortexed again and then
allowed to react for 5 min. Ammonium hydroxide (4 %
in water, 5 μl) was used to consume the excess aldehyde.
Deuterium labeling of the experimental samples was
performed in a similar manner except using formalde-
hyde-d2 (4 % in water, 5 μl). The tryptic digest derived
from the experimental sample was diluted with sodium
acetate buffer (100 mM, pH 5-6) and then labeled as de-
scribed above. The labeled peptides derived from either
control or experimental samples were blended and
desalted by C18 Easy-Tips (MST, Taipei) for additional
fractionation through strong cation exchange (SCX)
chromatography.
Off-line SCX fractionation of combined mixture
The desalted peptides were redissolved in 0.1 % formic
acid and fractionated using a SCX cartridge (5 μm,
Vydac, CA, USA). A total of ten fractions eluted with 5,
10, 20, 30, 40, 50, 60, 100, 200, and 500 mM of sodium
chloride were serially collected. The resulting fractions
were desalted by EasyTipsTM (C SUN, Taipei, Taiwan)
and subjected to LC-MS/MS analysis.
Mass spectrometric analysis and database searching
The dimethylated tryptic peptides were analyzed using a
tandem quadrupole time-of-flight (Q-TOF) mass spec-
trometer (Micromass, UK) equipped with a nanoflow
CapLC system (Waters). The scan range was from m/z
400 to 1600 for MS and m/z 50 to 2000 for MS/MS. For
sequencing, the MS/MS spectra were obtained through
a survey scan and the automated data-dependent MS
analysis was performed by the dynamic exclusion feature
built into the MS acquisition software. The MS/MS raw
data was processed into a PKL file format using MassLynx
4.0 (Micromass, UK). The resulting PKL file was searched
using the Mascot search engine v2.2 (Matrix Science, UK)
with the following search parameters: (1) protein database
was set to be Swiss-Prot; (2) taxonomy was set as Homo
sapiens (human); (3) one trypsin missed cleavage was
allowed; (4) the precursor and product ion mass tolerance
was set at 0.4 Da/0.2 Da; (5) carbamidomethyl (C) was
chosen for fixed modification; (6) oxidation (M), deami-
dated (NQ), Dimethyl (K), Dimethyl (N-term), Dimethyl:
2H(4) (K), Dimethyl:2H(4) (N-term) were chosen for vari-
able modifications; (7) proteins with scores above the sig-
nificance threshold (p < 0.05) were shown as significant
hits. All MS/MS spectra of identified peptides derived
from membrane proteins were further verified by manual
interpretation, in particular, using a1 ion in each MS/MS
spectrum to verify the N-terminus of the corresponding
peptide [42]. The subcellular location and functional
annotation of the identified proteins were elucidated
by UniProt knowledgebase (Swiss-Prot/TrEMBL) and
Gene Ontology Database. The intensity ratios of isotopic
isomers were calculated based on peak area or peak inten-
sity from selective ion chromatograms or alternatively, all
of the spectra containing both mass peaks of D4- and H4-
labeled peptides were combined to produce a composite
MS spectrum. The ratios of the D4- and H4-labeled pep-
tides in the composite MS spectra were calculated from
the sum of the peak heights of the first three isotopic
peaks. Proteins with relative ratio more than 2 were
regarded as over-expressed. The accession numbers of
these over-expressed surface membrane proteins from
HKTB treated THP-1-derived DCs were put together and
further correlated by STRING database with known and
predicted protein-protein interactions (http://string-db.
org/newstring_cgi/show_input_page.pl).
Western blotting
THP-1-derived DCs were treated with LPS, TNF-α or
HKTB. CD13 protein levels were analyzed by Western
blotting to confirm and validate significance of the prote-
omic findings. Each protein sample was mixed with an
electrophoresis buffer containing 2 % SDS and 5 % β-
mercaptoethanol and boiled for 10 min. Proteins (5 μg)
were separated by electrophoresis on a 10 % SDS-
polyacrylamide gel. The fractionated proteins were elec-
troblotted onto a polyvinylidene difluoride membrane.
The membranes were blocked at least 2 hrs in 5 % BSA,
0.1 % Tween 20 in TBS (TBST) and then incubated with
CD13 antibodies (1:1000 dilution, Abcam, MA, USA), for
1 hr. After washing in TBST, membranes were incubated
with peroxidase-conjugated secondary antibodies for 1 hr,
and proteins were detected using an enhanced chemilu-
minescence detection system (PerkinElmer Life and Ana-
lytical Sciences, Boston, USA).
Human dendritic cells culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from the whole blood of healthy adult volunteers
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by Ficoll-Paque gradient centrifugation. Monocytes were
sorted by incubating PBMCs with CD14 microbeads
(Miltenyi Biotec) and then the CD14-positive cells were
separated by means of a magnetic force. Dendritic cells
were generated by culturing monocytes for five days in
RPMI-1640 medium with 10 % FBS in the presence of
100 ng/ml GM-CSF and 100 ng/ml IL-4 (Peprotech
Ltd). Monocyte-derived DCs were then treated with
HKTB solution for two days.
Flow cytometry
Cells were stained with PE-conjugated anti-CD13 anti-
body (clone WM15, BD Pharmingen TM, San Jose, CA,
USA). The mean fluorescence intensity of stained cells
was measured by FACS Calibur flow cytometry and ana-
lyzed by using CellQuest software (BD Bioscience).
Live M tuberculosis preparation M. tuberculosis were
obtained from a clinical virulent strain identified by the
Mycobacteriology Laboratory, MacKay Memorial Hos-
pital. Firstly, M. tuberculosis was identified by a MPT64
rapid test, arylsulfatase test, and nitrate reductase assay.
The identified strain was further confirmed by a commer-
cial TB-PCR kit (COBAS, Taqman MTB test, Roche). Seed
stocks of the collected strain were maintained in small ali-
quots at -80 °C. The M. tuberculosis used throughout this
study was prepared from the seed stocks by culturing on
7H11 agar plate for 3 weeks at 37 °C in 10 % CO2 humidi-
fied atmosphere. The culture medium used was a 7H9
broth supplemented with 0.2 % glycerol, 0.05 % Tween-80
and 10 % oleic acid-albumin-dextrose-catalase enrichment
(Difco, Becton Dickinson and Company, MD, USA) to an
optical density at 600 nm of 0.3 and used as the inoculum.
Confocal microscopy
Dendritic cells were cultured on 18-mm-diameter cover-
glass placed in 12-well culture plate and infected with M.
tuberculosis labeled with Auramin-Rhodamin T. At vari-
ous time points, unbound bacteria were washed away with
PBS and cells were fixed in 4 % formalin. CD13 were
stained with Cy-Chrome 5 (Cy5)-conjugated anti-CD13
antibody, and nuclei were stained with 4’-6-Diamidino-2-
phenylindole (DAPI). Samples were analyzed by Leica
TCS SP5 confocal laser scanning microscopy and quanti-
fied by Leica LAS AF software. Use the Leica software
profile quantification tool to manually trace a lineal region
of interest in each cell that is subjected to analysis. Subse-
quently, obtain graphs displaying the intensity profiles of
CD13/M. tuberculosis (green/red channel).
T-cell proliferation assay
T cells were purified from CD14-negaitive cells by using
the Dynal T cell negative isolation kit (Dynal Biotech
Ltd; purity routinely >90 %). T cells were labeled with
5 μM CFSE dye (Invitrogen) for 10 min at 37 degree,
washed once, and resuspended in RPMI-1640 medium
with 10 % FBS to a final concentration of 2 × 106 cells/ml.
CFSE-labebled T cell (2 × 105) were incubated with au-
tologous antigen-loaded dendritic cells (4 × 104) (5 T cells:
1 DC) as previously described [43]. Cells were incubated
for 6 days and CFSE dilution was measured by flow cy-
tometry. The proliferation index was calculated by the for-
mula: % of dividing cells/% of non-dividing cells.
Statistical analysis
Paired t test was used for analysis. Data are reported as
the mean ± SEM. Statistical analysis was performed using
Prism 3.0 software (GraphPad Software Inc.). Two-sided
tests were used and a P value of < 0.05 was considered sta-
tistically significant.
Additional file
Additional file 1: Table S1. A total of 184 proteins derived from the
membrane fraction of THP-1-derived DCs treated with or without HKTB.
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